Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 3:10:1072435.
doi: 10.3389/fsurg.2023.1072435. eCollection 2023.

Small bowel neuroendocrine tumors: An analysis of clinical presentation, diagnostic workup and surgical approach-A single center retrospective study

Veronika Kroepfl  1 , Ruben Bellotti  1 , Elisabeth Gasser  1 , Katharina Esswein  1 , Hannah Esser  1 , Reinhold Kafka-Ritsch  1 , Dietmar Öfner  1 , Alexander Perathoner  1
Affiliations

Small bowel neuroendocrine tumors: An analysis of clinical presentation, diagnostic workup and surgical approach-A single center retrospective study

Veronika Kroepfl et al. Front Surg. .

Abstract

Background: Neurocrine neoplasms (NEN) of the small bowel (SBNEN) are a rare entity and mostly asymptomatic. The aim of this study was to explore trends in the clinical presentation, diagnostic workup, surgical approach and oncological outcome in patients with SBNEN at our surgical department.

Materials and methods: All patients who underwent surgical resection for SBNEN from 2004 to 2020 at our department were enrolled in this single center retrospective study.

Results: A total of 32 patients were included in this study. In most cases, the diagnosis was based on incidental findings during endoscopy or radiographic imaging (n = 23; 72%). Twenty cases had a G1 tumor and 12 cases a G2 tumor. The 1-, 3- and 5-year overall survival (OS) were 96%, 86% and 81%, respectively. Patients with a tumor more than 30 mm had a significantly lower OS (p = 0.01). For G1 tumors, the estimated disease-free survival (DFS) was 109 months. Again, the DFS was significantly lower when the tumor had more than 30 mm in diameter (p = 0.013).

Conclusion: Due to the mostly asymptomatic presentation, the diagnostic workup can be difficult. An aggressive approach and a strict follow-up seem to be important for the oncological outcome.

Keywords: diagnostic workup; neuroendocrine tumors; oncological outcome; small-bowel neuroendocrine tumors; surgical treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) 1-, 3- and 5-year overall survival. (B) 1-, 3- and 5 year disease-free survival.
Figure 2
Figure 2
(A) Overall survival, stratified by gender. (B) Disease-free survival, stratified by gender.
See this image and copyright information in PMC

References

    1. Scott AT, Howe JR. Management of small bowel neuroendocrine tumors. J Oncol Pract. (2018) 14(8):471–82. 10.1200/JOP.18.00135 - DOI - PMC - PubMed
    1. Larouche V, Akirov A, Alshehri S, Ezzat S. Management of small bowel neuroendocrine tumors. Cancers. (2019) 11(9):1395. 10.3390/cancers11091395 - DOI - PMC - PubMed
    1. Perren A, Couvelard A, Scoazec JY, Costa F, Borbath I, Delle Fave G, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology: diagnosis and prognostic stratification. Neuroendocrinology. (2017) 105(3):196–200. 10.1159/000457956 - DOI - PubMed
    1. Wang R, Zheng-Pywell R, Chen HA, Bibb JA, Chen H, Rose JB. Management of gastrointestinal neuroendocrine tumors. Clin Med Insights Endocrinol Diabetes. (2019) 12:1179551419884058. 10.1177/1179551419884058 - DOI - PMC - PubMed
    1. Xavier S, Rosa B, Cotter J. Small bowel neuroendocrine tumors: from pathophysiology to clinical approach. World J Gastrointest Pathophysiol. (2016) 7(1):117–24. 10.4291/wjgp.v7.i1.117 - DOI - PMC - PubMed

LinkOut - more resources